Kweon YO - Search Results

1

CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.

Schwabe RF, Schnabl B, Kweon YO, Brenner DA. Schwabe RF, et al. Among authors: kweon yo. J Immunol. 2001 Jun 1;166(11):6812-9. doi: 10.4049/jimmunol.166.11.6812. J Immunol. 2001. PMID: 11359840

2

Gliotoxin-mediated apoptosis of activated human hepatic stellate cells.

Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. Kweon YO, et al. J Hepatol. 2003 Jul;39(1):38-46. doi: 10.1016/s0168-8278(03)00178-8. J Hepatol. 2003. PMID: 12821042

3

The role of Smad3 in mediating mouse hepatic stellate cell activation.

Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA. Schnabl B, et al. Among authors: kweon yo. Hepatology. 2001 Jul;34(1):89-100. doi: 10.1053/jhep.2001.25349. Hepatology. 2001. PMID: 11431738

4

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burchardt E, Schoonhoven R, Brenner DA, Fried MW. Kweon YO, et al. J Hepatol. 2001 Dec;35(6):749-55. doi: 10.1016/s0168-8278(01)00218-5. J Hepatol. 2001. PMID: 11738102 Clinical Trial.

5

[Pretreatment ALT level and histologic activity as predictors of HBeAg loss in lamivudine treatment for chronic hepatitis B].

Kweon YO, Kang KH. Kweon YO, et al. Korean J Hepatol. 2004 Mar;10(1):31-41. Korean J Hepatol. 2004. PMID: 15096715 Korean.

6

[Chronic hepatitis B. Dose and treatment duration of regimen].

Kweon YO. Kweon YO. Korean J Hepatol. 2005 Mar;11(1):13-6. Korean J Hepatol. 2005. PMID: 15788878 Review. Korean. No abstract available.

7

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.

Lee KS, Kweon YO, Um SH, Kim BH, Lim YS, Paik SW, Heo J, Lee HJ, Kim DJ, Kim TH, Lee YS, Byun KS, Kim D, Lee MS, Yu K, Suh DJ. Lee KS, et al. Among authors: kweon yo. Clin Mol Hepatol. 2017 Dec;23(4):331-339. doi: 10.3350/cmh.2016.0040. Epub 2017 Sep 26. Clin Mol Hepatol. 2017. PMID: 28946736 Free PMC article. Clinical Trial.

8

[Assessment of quality of life and associated factors in patients with chronic viral liver disease].

Park CK, Park SY, Kim ES, Park JH, Hyun DW, Yun YM, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YH, Park SG. Park CK, et al. Among authors: kweon yo. Taehan Kan Hakhoe Chi. 2003 Sep;9(3):212-21. Taehan Kan Hakhoe Chi. 2003. PMID: 14515039 Korean.

9

Clinical, biochemical, and pathological characteristics of clevudine-associated myopathy.

Tak WY, Park SY, Cho CM, Jung MK, Jeon SW, Kweon YO, Park JY, Sohn YK. Tak WY, et al. Among authors: kweon yo. J Hepatol. 2010 Aug;53(2):261-6. doi: 10.1016/j.jhep.2010.03.006. Epub 2010 Apr 18. J Hepatol. 2010. PMID: 20466447

10

Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis.

Kim KH, Jang BK, Chung WJ, Hwang JS, Kweon YO, Tak WY, Lee HJ, Lee CH, Suh JI. Kim KH, et al. Among authors: kweon yo. Korean J Hepatol. 2011 Sep;17(3):220-5. doi: 10.3350/kjhep.2011.17.3.220. Korean J Hepatol. 2011. PMID: 22102389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page